Mesonephric Gynecologic Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Mesonephric Gynecologic Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05787561

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

This study will test if Avutometinib (VS-6766) in combination with Defactinib is an effective treatment for advanced or recurrent mesonephric gynecologic cancer…

United States40 participantsStarted 2023-03-15

Treatment: Avutometinib (VS-6766), Defactinib

Mesonephric Gynecologic Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

All recent trials (1 shown)